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Abstract
Canine Chronic Ulcerative Stomatitis is a spontaneously occurring inflammatory disease of the
oral mucosa. An immune-mediated pathogenesis is suspected though not yet proven. We
have recently reported on the clinical and histologic features, and identification of select leuko-
cyte cell populations within the lesion. A clinical and histologic similarity to oral lichen planus of
people was proposed. In the present study, these initial observations are extended by examin-
ing lesions from 24 dogs with clinical evidence of chronic ulcerative stomatitis. Because dogs
with chronic ulcerative stomatitis often have concurrent periodontal disease, we wondered if
dental plaque/biofilm may be a common instigator of inflammation in both lesions. We hypothe-
sized that dogs with chronic ulcerative stomatitis would exhibit a spectrum of pathologic
changes and phenotype of infiltrating leukocytes that would inform lesion pathogenesis and
that these changes would differ from inflammatory phenotypes in periodontitis. Previously we
identified chronic ulcerative stomatitis lesions to be rich in FoxP3+ and IL17+ cells. As such, we
suspect that these leukocytes play an important role in lesion pathogenesis. The current study
confirms the presence of moderate to large numbers of FoxP3+ T cells and IL17+ cells in all
ulcerative stomatitis lesions using confocal immunofluorescence. Interestingly, the majority of
IL17+ cells were determined to be non-T cells and IL17+ cell frequencies were negatively cor-
related with severity on the clinical scoring system. Three histologic subtypes of ulcerative sto-
matitis were determined; lichenoid, deep stomatitis and granulomatous. Periodontitis lesions,
like stomatitis lesions, were B cell and plasma cell rich, but otherwise differed from the stomati-
tis lesions. Direct immunofluorescence results did not support an autoantibody-mediated auto-
immune disease process. This investigation contributes to the body of literature regarding
leukocyte involvement in canine idiopathic inflammatory disease pathogenesis.
Introduction
Chronic ulcerative stomatitis (CCUS) is a chronic, progressive and painful oral inflammatory
disease that is poorly responsive to current therapeutic approaches and has an incompletely
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understood pathogenesis. We have previously described the clinical, radiographic, clinicopath-
ologic and histopathologic characteristics of this disease.[1] We have further provided a pre-
liminary and qualitative characterization of the inflammatory cell infiltrate that characterizes
CCUS lesions. Specifically, we showed that CCUS lesions are rich in both B and T lympho-
cytes, as well as IL-17 producing cells. The current study is focused on further elucidating the
immuno-pathogenesis of this poorly understood and devastating disease.
Further use of the pseudonym Canine Ulcerative Paradental Stomatitis has been discour-
aged as approximately 40% of the lesions occur adjacent to edentulous areas and are therefore
not paradental. The clinical findings of CCUS are characterized by painful oral mucosal ulcers
of varying size, pattern, appearance, and distribution. The disease is refractory to common
medical therapies, and many clinicians have resorted to full-mouth tooth extraction as a sal-
vage measure. We have introduced a clinical scoring system, called the Canine Ulcerative Sto-
matitis Disease Activity Index (CUSDAI) in an attempt to quantify disease severity and
response to various therapeutic regimens “S1 Table”.[1] CCUS histopathology typically fea-
tures a densely arrayed inflammatory cell infiltrate at the interface between the superficial
mucosal epithelium and subepithelial connective tissue (lichenoid infiltrate) that is composed
of B cells, plasma cells, CD3 T cell subsets (including FoxP3+), neutrophils, and fewer mast
cells within the deep submucosa.[1] An initial evaluation using multi-color immunofluores-
cence (IF) on a small number of CCUS cases, revealed moderate numbers of infiltrating IL17
+ cells; interestingly the majority of these cells were determined to be CD3 negative.[1] Given
the fact that CCUS patients respond poorly to current medical treatment strategies, there is a
strong interest to better define the underlying pathogenesis of CCUS.
Detailed description of the various inflammatory cell infiltrates is a critical first step in
understanding the pathogenesis. Since expansion of the T helper 1 (Th), Th2 paradigm, the
relevance of Th17 cells, and their integral control of the tissue-based immune response along-
side T regulatory (Treg) cells has been foundational.[2, 3] The IL17 family of cytokines are
potent inducers of inflammation and help to protect against multiple microbial pathogens.
However, these cytokines may also contribute to the tissue destruction that occurs in chronic
inflammatory and immune-mediated diseases. The potent IL17 cytokine is secreted by special-
ized CD4 T cells, as well as other T cells, innate-like lymphocytes and other innate immunity
cell types.
The balance between pro-inflammatory IL17 producing cells and immunoregulatory Treg
cells in various types of inflammation and autoimmune diseases continues to receive intense
investigation.[4, 5] Treg cells are thought to be critical regulators of the immune response and
T-cell tolerance. It is postulated that in the human oral inflammatory disease, oral lichen pla-
nus (OLP), Treg cells are functionally deficient, and thereby fail to control the initiation and
maintenance of this autoimmune disease.[6] In dogs, decreased numbers and function of Treg
cells in inflammatory bowel disease and intestinal lymphoma has been shown to contribute to
pathogenesis.[7, 8] In CCUS lesions, infiltrating FoxP3+ cells have been proposed to play a
role in lesion pathogenesis.[1] Whether these lesion-associated Tregs are functionally deficient
or play some kind of balancing role with proinflammatory IL17+ cells, awaits clarification.
In this CCUS study, tissues from dogs with periodontal disease (PD) were utilized as a com-
parator lesion as PD is one of the most common oral inflammatory diseases in dogs,[9] and
often occurs concurrently in dogs with CCUS. Although the anatomic locations of CCUS
lesions are known to vary, it was initially observed that dogs had lesions within the buccal
mucosa adjacent to teeth (paradental). Many of these “paralesional” teeth had attached plaque
biofilm or mineralized calculus, suggesting the possibility that the CCUS lesion might share
pathologic features with the biofilm-associated PD lesion. In both humans and dogs, periodon-
titis is an important chronic inflammatory disease triggered by the oral microbiome and
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altered by the function or dysfunction of the host’s innate, and/or adaptive immune system.
[10, 11] Given that the role of periodontal disease in the pathogenesis of CCUS is not fully
understood, we have included a PD control group in an effort to shed light on potentially
shared important pathogenic mechanisms.
Our goal for the present study was to better define the immunopathogenesis of CCUS by
objectively quantifying inflammatory cell infiltrates, determining the pattern of immunoglob-
ulins and complement fragment deposition within CCUS lesions and correlating these finding
with clinical findings.
Materials and methods
Ethical statement
For all of the dogs in this study, tissue sampling was performed under general anesthesia
(induction with Propofol 4 mg/kg and Valium 0.5 mg/kg intravenous, maintenance with iso-
flurane inhalant), with appropriate regional local anesthesia (Bupivacaine 0.5% ml amount
dependent on animal size) and post-operative analgesic (Hydromorphone 0.5 mg/kg subcuta-
neous) administration. The study conformed to American Animal Hospital Association
Guidelines for Dental Care. [12] Client consent forms were discussed and signed. Prospec-
tively, the University of California, Davis IACUC counseled that since samples were obtained
as part of dental treatment, an IACUC protocol was not required. No adverse events were doc-
umented as a result of tissue acquisition.
Study design
This was a descriptive study of the leukocytic cell types within the mucosal tissues of client-
owned dogs clinically diagnosed with chronic ulcerative stomatitis. Randomization was not
applicable. Pathologists (BG Murphy and A Kol) were blinded to patient details and CUSDAI
scores.
Animals and clinical assessment
Twenty-four dogs with clinically evident CCUS were prospectively enrolled in this study from
the clinical caseloads of the first (JG Anderson, 13 cases) and fourth (B Stapelton, 11 cases)
authors “S2 Table”. Patient guardians enrolled by both clinicians read and signed a patient
release form “S3 Table”. Animals were housed in their home environment. Inclusion criteria
included two or more chronic erosions or ulcers in the buccal mucosal tissue opposite teeth or
edentulous areas. Exclusion criteria included animals in renal failure, with previously diag-
nosed autoimmune or immune-mediated disease; and those dogs who were currently receiv-
ing immune-suppressing drug therapy. A CUSDAI score was determined and assigned and a
generalized periodontal disease stage score (1 to 4) was determined for each case using clinical
probing and full mouth dental radiographs.
For the CCUS patients, an approximately 10 X 10-mm section of affected oral mucosa was
surgically removed while the patient was under general anesthesia. For some smaller lesions,
this represented an excisional biopsy; and in other larger lesions, the biopsy was intralesional.
The biopsy tissue was trisected, and sub-specimens were immersed in 10% buffered formalin,
isotonic saline, or RNAlater Stabilization Solution (ThermoFisher Scientific). Fig 1. Tissues
immersed in RNAlater were cooled on ice and frozen at -70o C within 24 hours after collection
and were not further utilized in the present study. Tissues immersed in isotonic saline were
cooled on ice and stored for less than 24 hours prior to embedding for frozen sections. Saline-
immersed tissues were placed in OCT compound (Tissue-Plus, Fischer Healthcare) within a
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plastic embedding cassette (Tissue-Tek Cryomold, Sakura) and flash frozen by suspending the
cassette in 2-methylbutane (Fisher Chemical) cooled in a liquid nitrogen bath. The flash-fro-
zen OCT embedded tissue was then stored at -700 C until sectioned on a cryomicrotome
(Leica CM1860). The formalin treated mucosal tissues were fixed for a minimum of 48 hours,
further bisected or trisected as needed, placed into plastic embedding cassettes and routinely
processed for 4 micron-thick sections and affixed to positively charged glass slides (formalin-
fixed paraffin embedded (FFPE) sections).
For the ten control periodontal disease tissues; one or more affected teeth and adjacent soft
tissues (periodontal ligament and adjacent fragments of alveolar bone) were harvested from
extracted teeth-bone specimens of dogs with clinical evidence of Stage 3 or 4 periodontitis.
These samples were collected from the clinical caseload of the first author. After extraction,
teeth and associated soft tissues were immediately immersed in 10% buffered formalin for a
minimum of 48 hours and subsequently decalcified in 15% formic acid as needed to allow sec-
tioning (48–96 hours). Decalcified tissues were processed and affixed to glass slides as
described above. Normal canine lymph node tissue (n = 1) and canine buccal mucosa (n = 5)
were obtained from dogs euthanized at the University of California Davis, Veterinary Medical
Teaching Hospital for reasons unrelated to oral disease undergoing unrestricted necropsies.
These tissues were fixed in 10% buffered formalin for a minimum of 48 hours, bisected and
routinely processed onto positively charged glass slides as described above.
Histopathology
Mucosal CCUS lesions, teeth/periodontal tissue, normal lymph node tissue and normal buccal
mucosa tissue were stained with hematoxylin and eosin (HE) or toluidine blue according to
standard protocols. Tissue sections were examined using brightfield microscopy and digital
photographs were obtained using an Olympus BX41 microscope and Tucsen 16 MP digital
camera (Tucsen Photonics).
Fig 1. CCUS sample distribution.
https://doi.org/10.1371/journal.pone.0227386.g001
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Immunohistochemistry
Immunohistochemistry (IHC) assays were performed on 4-micron thick, formalin-fixed, par-
affin-embedded (FFPE) tissue sections mounted on positively charged slides and air dried
overnight. Sections were immune-labeled for CD3 (T cells), CD20 (B cells), Mum-1 (plasma
cells), CD204 (macrophage) or FoxP3 (Treg) cells. Specific antibodies and supporting citations
are summarized in Table 1.
Sections were deparaffinized in xylene and rehydrated through graded alcohols to phos-
phate buffered saline (PBS). Endogenous peroxidases were quenched with 0.3% hydrogen per-
oxide for 30 minutes in methanol prior to rehydration. CD3, CD20 and FoxP3 slides
underwent heat induced epitope retrieval (HIER) in Dako Target Retrieval Solution (Dako
S1699) for 30 minutes at 95o C and then cooled for 20 minutes. Mum-1 slides underwent
HIER treatment in EDTA buffer (Thermoscientific AP-9004-500) for 30 minutes at 95o C and
then cooled for 20 minutes. CD204 slides underwent HIER treatment in EDTA buffer pH 9.0
(VMTH) for 30 minutes at 95o C and then cooled for 20 minutes.
All of the tissue sections were blocked for 20 minutes in 10% normal horse serum diluted in
PBS. Primary antibodies and dilutions were as follows: rat anti-CD3, diluted 1:10; rabbit anti-
CD20 diluted 1:300; rat anti-FoxP3, diluted 1:100; rabbit anti-Mum1, diluted 1:100; mouse
anti-CD204, diluted 1:200.
BioCare Medical mouse-on canine HRP Polymer (MC541L) was applied for 30 minutes to
label mouse anti-CD204. BioCare Medical rabbit-on-canine HRP-Polymer (RC542L) was
applied for 30 minutes to label rabbit anti-Mum1, and anti-CD20. BioCare Medical rat
HRP-Polymer, 1-step mouse absorbed (BRR4016L) was applied for 30 minutes to label rat
anti-CD3 and anti-FoxP3. All bound antibodies were visualized with NovaRed for peroxidase
(Vector SK-4800), per manufacturer’s instructions). Sections were counterstained in Hema-
toxylin 1 (Fisher HealthCare, 22-220-101) for 10 seconds and Bluing Reagent (Fisher Health-
Care 220–106) for 2 minutes and air dried prior to attaching cover slips. A normal canine
lymph node was used as the positive control tissue for the leukocyte phenotyping.
Immunohistochemistry to identify CD4 or CD8 T cells was performed on non-formalin
fixed, flash-frozen tissue sections mounted on positively charged slides and air-dried over-
night. Slides were quenched for 10 minutes in 0.1M phosphate buffered saline (PBS), pH 7.4
(PBS) with 0.3% hydrogen peroxide and 0.1% sodium azide. Slides were rinsed in PBS, then
treated with 10% normal horse serum in PBS for 20 minutes. Without rinsing, the CD4 or
CD8 alpha antibody diluted 1:10 in PBS was applied and incubated for 1 hour. As both anti-
bodies are made in mouse, multiplexing is not feasible. Slides were rinsed with PBS, and
Table 1. Primary antibodies used in this study.
Target
antigen
Target species monoclonal/polyclonal Make Catalogue number Validation studies in dogs
CD3
CD3
Human
Human
Monoclonal (CD3-12)
Polyclonal
Bio-Rad
Dako
MAC1477
GA50361
[13]
[14, 15]
CD4 Canine Monoclonal (1E4) UC Davis Leukocyte Antigen Biology Lab, Dr. Peter
Moore
N/A [16]
CD8 Canine Monoclonal (JD3) UC Davis Leukocyte Antigen Biology Lab, Dr. Peter
Moore
N/A [16]
FoxP3 Mouse Monoclonal (FJK-16s) Invitrogen 14-5773-82 [17, 18]
IL17 Human Polyclonal R&D systems AF-317 [19]
CD20 Human Polyclonal ThermoFisher Scientific RB-9013 [20]
Mum-1 Human Monoclonal (BC5) BioCare Medical CRM352B [21, 22]
CD204 Human Monoclonal (SRA-E5) TransGenic KT022 [23, 24]
https://doi.org/10.1371/journal.pone.0227386.t001
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biotinylated anti-mouse antibody diluted 1:500 in PBS was applied for 20 minutes. Slides were
rinsed with PBS, and streptavidin-horseradish peroxidase diluted 1:500 in PBS was applied for
20 minutes. Bound antibodies were visualized with Vector’s NovaRed, per manufacturer’s
instructions. All incubations occurred at room temperature. Sections were counterstained with
Hematoxylin 1 (Fisher HealthCare,22-220-101) for 2 minutes, followed by Bluing Reagent
(Fisher HealthCare, 220–106) for 2 minutes, air dried followed by coverslip application.
All of the IHC assays were examined by a single pathologist (BGM). The semiquantitative
scoring system was based upon published standard. [25] The semi-quantitative scoring sys-
tems for canine mucosal mast cells, FoxP3+ and CD3+ T cells have been previously published.
[1] Semiquantitative ordinal scoring systems were developed for Mum1, CD4, CD8, CD20 and
CD204 and were based upon the percent of the surface area of a representative high power
(400x) magnified field that stained positively (IHC scoring system Table 2). A normal canine
mandibular lymph node and normal oral buccal mucosa were used as positive control tissues
for these leukocyte IHC stains. For each submitted tissue sample, the pathologist was blinded
to the signalment and clinical severity score.
Immunofluorescence and direct immunofluorescence
Samples were stained for immunofluorescence (IF) as previously described. Briefly, FFPE tis-
sue sections were routinely deparaffinized in xylene and serial ethanol dilutions, following
heat-induced antigen retrieval (antigen retrieval buffer; Dako). Samples were further blocked
with normal donkey serum and FcR Blocking Reagent (Miltenyi) and incubated overnight
with rabbit anti-human CD3 polyclonal antibody (1:50 dilutio) and goat antihuman IL17 poly-
clonal antibody (1:100 dilution) or rat anti-FoxP3 (1:200 dilution). Twenty-four hours later,
slides were extensively washed and treated with donkey anti-rabbit Alexa Fluor 488 and
Table 2. IHC Semi-quantitative scoring system.
1Mast cells (T. blue)- # of cells/200x field Scoring System
none 0
1-4/200x field 1+
5-20/200x field 2+
20+/200x field 3+
1FoxP3 (IHC)- # cells/200x field
none 0
1-5/200x field 1+
6-20/200x field 2+
21+/200x field 3+
1T cells (CD3 IHC)- % surface area (400x)
CD4 (frozen IHC)
CD8 (frozen IHC)
1B cells (CD20 IHC)
Plasma cells (mum1)
Macrophages (CD204)
none 0
<20% of 400x field 1+
20–50% of 400x field 2+
51% + of 400x field 3+
https://doi.org/10.1371/journal.pone.0227386.t002
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donkey anti-goat Alexa Fluor 555 or donkey anti-rat Alexa Fluor 594 (ThermoFischer Scien-
tific). All secondary antibodies were used at 1:400 dilution. Finally, nuclei were labeled with
DAPI (ThermoFischer Scientific). All immunohistochemistry and immunofluorescence stud-
ies had several layers of negative and positive controls to ensure appropriate interpretation of
our findings. Specifically, we have used a ‘No antibody’ control to determine the level of tissue
auto-fluorescence and ‘No primary antibody control’ to determine the level of non-specific
secondary antibody binding. For positive controls we have used canine lymph node sections
which contain the various immune cell subsets. Moreover, cell subset distribution within the
lymph node tissue was further used to evaluate our positive controls. Five random images
magnified at 200x were acquired from each section with a super-resolution confocal micro-
scope (Leica) and analyzed using image analysis software (Image J, NIH and lmaris, Oxford
Instruments). A “reactive” (hyperplastic) canine mesenteric lymph node was used as a positive
control. The negative control slides omitted the primary antibodies.
For direct immunofluorescence (DIF), formalin-fixed, paraffin-embedded biopsy sections
of buccal mucosa from 17 dogs diagnosed with CCUS were available for detection of tissue-
bound IgG, IgM and IgA antibodies and complement C3 using DIF. Sections of buccal mucosa
from five healthy dogs served as controls. All tested tissues were deparaffinized, rehydrated and
digested with 0.1% trypsin (MilliporeSigma, St. Lois, MO, USA) for 30 minutes at 37 Celsius.
Tissues were rinsed in PBS, subsequently blocked with 1% newborn calf serum (MilliporeSigma,
St. Lois, MO, USA) and the sections were incubated at room temperature for 30 minutes with
either rabbit anti-canine IgG (1:400; Alexa Fluor-488 conjugated, Jackson ImmunoResearch,
West Grove, PA, USA), goat anti-canine IgM (1:200; FITC conjugated, Bethyl, Montgomery,
TX, USA), goat anti-canine IgA (1:400; FITC conjugated, Bethyl, Montgomery, TX, USA) or
goat anti-canine C3 (1:100; FITC conjugated, Bethyl, Montgomery, TX, USA) antibodies.
Lymph node and mucosal sections from CCUS and healthy dogs in which antibody was
replaced by PBS served as positive and negative controls, respectively. Finally, all tissues were
mounted with Vectashield Antifade mounting medium with a nuclear counterstain DAPI (Vec-
tor Laboratories, Burlingame, CA, USA). Sections were evaluated using a fluorescent micro-
scope and representative images were obtained. The oral mucosa tissues were evaluated for
presence of immunostaining within the mucosal epithelium (intercellular, intracellular or
nuclear), at the basement membrane level (continuous, patchy) and within the lamina propria.
The staining intensity was graded subjectively as 0 = none, 1 = mild, 2 = moderate, 3 = strong.
Statistical analyses
All statistics were performed with GraphPad Prism 7.0. Data was tested for normality with the
Shapiro-Wilk test to inform the use of parametric vs non-parametric methods in downstream
analysis. A non-parametric Kruskal-Wallis ANOVA test was used to identify differences in
within a group of three or more means. Where differences were identified, non-parametric t
tests (Mann-Whitney test) were used to explore differences between means. Spearman’s rank
correlation co-efficiency was used to determine association between sex, CUSDAI scores, dis-
ease variants and leukocyte indices. A P value < 0.05 was considered to be significant.
Results
Histopathology
The morphologic diagnoses for all of the CCUS lesions were consistent with a submucosal
interface mucositis (pleocellular stomatitis) as previously described. (1) However, three rela-
tively distinct histologic subtypes of CCUS emerged, i) granulomatous inflammation featuring
a predominance of histiocytic cells (n = 3), ii) lichenoid inflammation (interface mucositis)
Immunopathogenesis of canine chronic ulcerative stomatitis
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(n = 12), and iii) deep stomatitis in which the inflammatory infiltrate extended down into the
deep buccal mucosa and skeletal muscle of the lip (n = 10). (Fig 2A–2D) In all CCUS subtypes,
the overlying epithelium was either eroded, ulcerated and/or hyperplastic and lymphoid folli-
cles were infrequently present in the submucosal connective tissue. The pleocellular lesions
generally featured an abundance of infiltrating neutrophils, lymphocytes and plasma cells
forming sheets and clusters. Small numbers of mast cells were typically identified in the deep
submucosa while eosinophils were not identified. The number of infiltrating macrophages in
the CCUS lesion varied by subtype and macrophages containing black melanin granules were
infrequently present within the superficial lamina propria. The three histologic subsets did not
differ in their mean clinical index of severity (i.e.CUSDAI), though the only two granuloma-
tous lesions came from dogs with high CUSDAI scores (24 and 26).
Immune cell infiltrate
Subjectively, CCUS lesions appeared to have a predominance of infiltrating B cells and plasma
cells over T cells and T cell subsets. However, the IHC-based semi-quantitative scoring system
Fig 2. Histologic subtypes of CCUS. A-Lichenoid stomatitis-CASE G 100x; B-Deep stomatitis-CASE V 40x (yellow 445 arrowheads-inflamed skeletal
muscle); C-Granulomatous stomatitis-CASE U 100x (inset-446 histiocytic inflammation, 200x) D-Clinical score (CUSDAI) versus CCUS histologic subtype.
https://doi.org/10.1371/journal.pone.0227386.g002
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indicated that the ordinal numbers of all of these cell types were statistically inseparable (Fig
3). There were no significant differences between the mean IHC scores for any of these leuko-
cyte subsets within the CCUS lesions.
B cells and plasma cells were present in the lamina propria and in lymphoid follicles (when
present) but did not infiltrate into the epithelium. CD3+ T cells and FoxP3+ were most
numerous in the lamina propria and occasionally infiltrated into the overlying mucosal epithe-
lium. CD204+ cells (macrophages) were less well represented in the CCUS lesion with a mean
ordinal score of 1.7. Macrophages were generally present at the interface of the deep lamina
propria and the muscular layer of the lip. However, in the granulomatous variant of CCUS,
macrophages were numerous (semiquantitative score of 3), tended to form expansive sheets
and were superficially located. Neutrophils were abundant in most of the CCUS lesions, espe-
cially subjacent to ulcerated regions. Mast cells were moderately common in the CCUS lesion
with an average of 5–20 cells/per 200x field and were generally located deep within the lamina
propria. Within the CCUS population, there were 14 cases with Stage 1 or 2 PD, two with
Stage 3 PD, and ten with Stage 4 PD. Differences in the numbers of infiltrating mast cells and
CD204+ cells, between these groups were not statistically significant.
All immune cell subsets that were investigated (i.e. B lymphocytes, T lymphocytes, plasma
cells, T helpers, cytotoxic T cells, macrophages and Treg) were increased in CCUS lesions com-
pared with healthy controls. While infiltrating B cells and plasma cells did not differ between
PD lesions and CCUS lesions, the rest of the tested immune cells were higher in CCUS.
Comparative results
In the normal buccal mucosa, small numbers of mast cells, CD3, CD4, CD8 and CD204+ cells
were identified within the lamina propria while very few B cells (CD20 or plasma cells) were
identified and FoxP3 + cells were not identified. The number of infiltrating leukocytes was sig-
nificantly higher in the CCUS lesions relative to the normal canine buccal mucosa. The com-
plete data set is available, “S4 Table”.
Fig 3. Leukocyte subsets- CCUS versus periodontitis controls.
https://doi.org/10.1371/journal.pone.0227386.g003
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In the tooth-associated periodontitis lesions, the inflamed periodontal tissue often repre-
sented a small proportion of the histologic section, and there were difficulties with the IHC
stained sections “washing off the slides”. Therefore, only ten of fifteen PD cases were examined
with the slate of immunohistochemical assays. In these ten examined PD lesions, the minimal
periodontal tissues attached to the tooth root cementum was multifocally infiltrated by large
numbers of lymphocytes and plasma cells and fewer neutrophils. Interestingly, very few CD3,
CD4, CD8, CD204, FoxP3+ and mast cells were identified in the periodontitis lesions. In com-
parison to the CCUS lesions, CD3, CD4, CD8, mast cells, CD204 and FoxP3+ cell numbers
in periodontitis lesions were significantly less, while the numbers of infiltrating CD20 and
Mum1+ plasma cells were indistinguishable between these two lesions.
Immunofluorescence
The 23 examined CCUS lesions had markedly increased numbers of CD3+ T cells within the
epithelial-lamina propria interface relative to normal canine oral mucosa. (Fig 4) IL17+ cells
were not identified in the normal control mucosa. CD3+ T cells expanded both the lamina
propria and infiltrated into the epithelium, with a median of 158 CD3+ T cells per 20x field
(range 6–731). As expected, FoxP3 staining was localized to nuclei of cells that were also CD3+
(i.e. T cells). FoxP3+ T cells were noted in all but one of the samples (n = 16) and have
accounted for 4.1% of the T cells in the sample (range 0.0–17). Strong cytoplasmic expression
Fig 4. T helper subset distribution in CCUS lesions. A -Normal canine oral mucosa illustrates very few CD3+ T cells (white arrows) that are distributed at the
mucosal–submucosal interface (A, stitched 20x tile image); B -Co-labeling of CD3 (green) and FoxP3 (red) reveals abundant FoxP3+ T cells that are noted with the
submucosa of CCUS lesions; C-IL17 (red) and CD3(green) co-staining reveals marked infiltration of sub-epithelial and mucosal tissues with CD3+T cells and IL17
producing cells. Note that most of the IL17 producing cells (i.e. red) are not double labeled with CD3 (i.e. green) indicating that IL17 producing cells are primarily non-T
cells. D—Close up (630x) image illustrates a single positive, IL17, cell (white arrow), a single positive CD3 T cell (white arrow head) and a group of double positive (i.e.
IL17/CD3) IL17 producing T cells (asterisk). E—No significant differences were identified in the frequencies of CD3+/FoxP3+ cells, CD3+ cells, IL17+ cells and DP
positive cells between the three histologic variants.
https://doi.org/10.1371/journal.pone.0227386.g004
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of IL17 in scattered IL17+ cells was noted in all but one of the samples (n = 22) with a median
of 47.8 cells/20x field (range 0–312). Consistent with previous findings, we noted that very few
cells were CD3+/IL17+ double positive (DP). DP cells accounted for a median of 1.6% of the
CD3+ T cells (range 0–11) and a median of 7.7% of the IL17+ cells (range 0–36). (Fig 4) While
the CD3+/IL17+ cells are likely to represent activated Th17 cells, the lineage of the CD3-/IL17
+ cells was not determined. Many cells with segmented nuclei (granulocytes) were present and
were determined to be IL17 negative.
There was no significant difference between the three histologic CCUS subsets in the num-
ber of infiltrating T cells, IL17+ cells, the proportion of IL17+/CD3+ out of the total CD3+, the
proportion of IL17+/CD3+ out of the total IL17+ and number of infiltrating Treg (Fig 5). A
significant negative correlation (r = -0.467, p = 0.038) between the frequency of IL17+ cells in
the lesions and the CUSDAI was identified, suggesting that IL17 may have a physiologic/pro-
tective role in this disease process.
Direct immunofluorescence
Unique DIF staining patterns associated with known auto-immune skin diseases such as deep-
pemphigus, autoimmune subepidermal blistering skin diseases or lupus erythematosus were
not detected in CCUS lesions. Positive intracellular IF staining for different antibody classes
was seen within the lamina propria where it was associated with the infiltrating mononuclear
cells. IgG deposits were most numerous, followed by IgA and IgM. There was minimal C3
deposition.
Fig 5. T cell and IL17 producing cell subsets in CCUS histologic types. A-There was no statistically significant difference in the number of infiltrating T cells; B-IL17
+ cells; C and D-percent double positive (IL17+/CD3+); and E-Treg cells. F-A negative correlation was found between the numbers of IL17+ cells per 20x field and the
stomatitis disease activity index.
https://doi.org/10.1371/journal.pone.0227386.g005
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Patchy to diffuse IgG staining was seen in the epithelial mucosa of 7/17 cases, and 3+ IgG
staining was present in all cases. One case revealed patchy IgG staining in the basement mem-
brane zone (BMZ). There was no IgA found within the epithelial mucosa, and from rare to 3
+ staining in the submucosa of 13/17. Rare IgM was found in the epithelial mucosa of 1 case,
in the submucosa, no specific staining (NSS) was seen in 3 cases, rare in seven cases, 1+ in six,
2+ in 2 and 3+ in 1. Complement staining in the mucosa was seen in 1 case at 1+, rare in the
submucosa of 6, 1+ in two cases, 2+ in one case, and NSS in 9. (Fig 6A–6C), (Fig 7A–7D)
Discussion
CCUS is a pleocellular chronic inflammatory mucosal disease that includes three distinct his-
tologic subtypes. The histologic subtypes of CCUS, lichenoid stomatitis, deep stomatitis and
granulomatous stomatitis, may either represent a continuum disease process or three distinct
disease variants. The mean clinical disease score was most severe for the granulomatous vari-
ant (25/32). CCUS lesions feature a wide variety of infiltrating leukocytes with moderate to
large numbers of T cells (CD3, CD4, CD8, FoxP3), B cells (CD20, Mum1), IL17+ cells, macro-
phages (CD204) and mast cells. Though lesion associated neutrophils were not quantitated,
they were present in moderate to large numbers in most of the examined CCUS lesions.
Both FoxP3+ and CD3-/IL17+ cells are involved in CCUS pathogenesis. However, there
were no significant differences in the relative numbers of IL17+ cells and CD3+/IL17+ double
positive cells, nor in the cells of the different histologic subtypes, further obscuring the role of
IL17. The relatively high levels of Tregs (i.e. FoxP3+ T cells) in CCUS, did not vary between
patient clinical severity scores, clinical periodontitis scores, histologic subtypes, gender, or
CD3-/IL17+ cells. Whether Tregs in CCUS lesions play an anti-inflammatory role, alter
immunosuppression or disrupt mucosal tolerance remains to be determined.
Th17 cells have emerged as crucial regulators of tissue homeostasis and immunopathology
at the oral mucosal barrier.[26] The IL17 family of cytokines are known to be potent inducers
of inflammation and to help protect against invading pathogens; however, they can promote
autoimmune disease when working together with Th1 cells and accompanied by chronic
immune and inflammatory processes. At this point in our understanding of CCUS pathogene-
sis, the lesion appears to feature infiltration of mostly CD3 negative IL17+ cells. Neutrophils,
though numerous in the interface mucositis, seem to be IL17 negative. Although multiple
Fig 6. A-C Direct Immunofluorescence in health and CCUS, IgG. A-DIF–tissue-bound IgG–using gingival mucosa from a healthy dog (A) or dog with CUS (B, C); B-A
band of IgG positive cells in the lamina propria below the mucosal epithelium (green) with scattered IgG positive cells in deeper layers of the lamina propria; C-In rare
dogs, in addition to the IgG positive mononuclear cells in the lamina propria, a faint and patchy basement membrane zone deposit could be appreciated. Blue nuclear
staining = DAPI.
https://doi.org/10.1371/journal.pone.0227386.g006
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studies indicate that IL17 is primarily produced by CD4+ Th cells;[26] numerous other cell
types appear to be capable of producing IL17 including γδ T cells,[27, 28] natural killer T cells
(NKT), neutrophils,[29] monocytes, mast cells, dendritic cells, vascular smooth muscle cells
[26] and by follicular helper CD4 T (Tfh) cells.[30] Confocal microscopy indicates that IL17
+ cells in CCUS lesions are mononuclear in origin; thereby eliminating granulocytes. How-
ever, the precise determination of the IL17+ cell phenotype in CCUS lesions is a critical future
goal for a more complete understanding of disease pathogenesis.
Current CCUS data suggests that IL17+ cells may, in part, play some kind of protective role
as the clinical severity score is inversely correlated to the number of IL17+ cells within the
lesion. That is, as the clinical severity score decreased, the number of lesion-associated IL17
+ cells increased.
The role of IL17 in periodontal disease in people is uncertain, since IL17 has been shown to
promote bone destruction but is nonetheless essential to protect the host from pathogens,
including periodontopathic organisms.[31] Defects in Th17 cells and/or their signature cyto-
kines result in significant susceptibility to oral fungal infections.[32–34] As well, amplified/
Fig 7. A-D Direct Immunofluorescence in health and CCUS, IgM and IgA. DIF–tissue-bound IgM (A-B) and IgA(C-D)–using gingival mucosa from a healthy
dog (A, C) or dog with CUS (B, D). Positively stained mononuclear cells in the lamina propria and within mucosal epithelium depicted in green. Blue nuclear
staining = DAPI.
https://doi.org/10.1371/journal.pone.0227386.g007
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uncontrolled Th17 responses have been documented in periodontitis.[35–37] Recent evidence
has shown that Th17 cells are more osteoclastogenic than other T helper subsets such as Th1
or Th2. There is also evidence that the periodontopathogen Porphyromonas gingivalis pro-
motes an IL 17 environment in order to obtain nutrients from tissue breakdown products.[35,
38, 39] IL17 sits at the center of many complex diseases that integrate innate and adaptive
immune mechanisms and requires careful study to maximize host protective effects and mini-
mize host deleterious effects.
PD is the most common chronic inflammatory disease of dogs and often occurs in conjunc-
tion with CCUS lesions. In contrast to the highly pleocellular CCUS lesions, the independent
canine periodontitis lesions analyzed in this study were predominately characterized by a B
cell infiltrate (CD20 and Mum1) but not by infiltrating T cells, macrophages, mast cells or
FoxP3+ cells. PD is common in human patients and approximately 10% of the population will
develop severe periodontal disease.[40, 41] Studies in people have demonstrated that develop-
ment of periodontitis involves a switch from a gingivitis lesion, mainly mediated by T cells, to
one predominated by B cells and plasma cells.[42] In PD lesions, B cells have been shown to
have both protective and detrimental roles in settings of immunopathology.[43] The patho-
genesis of human PD seems to involve an interplay between the tooth-associated bacterial bio-
film and the host immune response. Severe periodontal destruction is associated with systemic
translocation of periodontal microbes and is linked to numerous systemic inflammatory con-
ditions, indicating that, in people, local immune/microbiome imbalance may affect systemic
inflammatory processes, either through increased microbial translocation, systemic inflamma-
tion, or shared immunological mechanisms.[35] The composition of the plaque-associated
microbiome in canines with ulcerative stomatitis has recently been determined, and similar
conclusions may be relevant. We, as yet, do not know how many IL17+ cells are present within
the non-CCUS periodontal disease lesions; though there seemed to be no difference in IL17
numbers between periodontal disease stages within the CCUS population. Implicit in our
understanding will be to determine the source of the IL17 in CCUS; and for severe periodonti-
tis if IL17 is present.
CCUS has multiple pathologic similarities to OLP in people.[1] OLP studies suggest
FoxP3+Tregs have a more prominent role in lesion pathogenesis when compared to IL17+
cells.[44] The majority of FoxP3+ cells in OLP were identified in the sub-epithelial infiltrate,
while IL17+ cells were found deeper in the stromal tissues.[45] As well, in human patients with
clinically erosive OLP lesions, Foxp3 mRNA expression was significantly lower in circulating
CD4+CD25+ T cells and tissue explants compared to patients with reticular lesions, and lowest
in patients with a history of OLP of more than one year or with a history of relapse.[46] This
study indicated that Foxp3 expression in patients with OLP was associated with the severity
and duration of the disorder, suggesting altered immunosuppression in the development, clin-
ical course and responsiveness to treatment. In another study, impaired suppressive function
of CD4+ CD25+ T cells was demonstrated in OLP patients indicating that Tregs in OLP are
frequently expanded but functionally deficient. The authors conclude that this may explain
why the increased Tregs in OLP fail to control the pathogenesis and development of this auto-
immune disease.[6] We propose for further investigation in CCUS that the high numbers of
FoxP3 may as well be deficient.
Consideration of the pathogenic mechanisms operating in OLP may be useful to CCUS dis-
ease inquiry. At the cellular level, OLP may result from an immunologically induced apoptosis
of the basal keratinocytes, due to cytotoxic CD8+ cell response on modified keratinocyte sur-
face antigen. IF in OLP revealed that FoxP3+ cells co-localized with T cells. Double labelling
immunofluorescence indicated co-localization of IL17 with tryptase (+) mast cells, solidifying
their role in pathogenesis. As there are large numbers of FoxP3+ cells in CCUS as well as IL17
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+ cells, we do not yet know which cell type is most important. Co-localization studies are
planned to determine if IL17+ cells are mast cells, thereby suggesting a role for CCUS as an
animal model for OLP.
One of the hallmarks of OLP diagnosis in human patients is “shaggy fibrinogen staining” at
the basement membrane zone on direct immunofluorescence.[47] Unfortunately, fibrinogen
DIF staining was not assessed in these CCUS lesions. DIF staining of the CCUS lesions did
reveal different classes of antibodies, IgG, IgA, and IgM, and very little complement, found
within mononuclear cells, which likely represent plasma cells infiltrating the lamina propria.
None of the tissue specific staining patterns associated with known autoimmune skin diseases
such as pemphigus, autoimmune subepidermal blistering skin diseases or lupus erythematosus
were observed. This pattern supports the inflammatory nature of CCUS, and perhaps the result
of directly cytotoxic T lymphocytes and not a classic auto-antibody immune mediated
pathogenesis.
For future analyses, serum samples from CCUS cases were banked, as were lesion tissue
samples for the determination of RNA expression. Flow cytometry or IF could be used to fur-
ther identify the IL17-expressing cell phenotype. If the source for IL17 can be determined,
then potential targeted therapeutics may be developed. Further clarification of the role of IL17
in this spontaneously occurring disease may provide a non-mouse model for other IL17 rich
diseases. Determination of the oral microbiome from plaque samples of CCUS lesions is com-
plete and analysis may reveal a dysbiotic trigger in mucosal immunopathology. Other studies
are required to determine the function of FoxP3 in CCUS; and whether its exact role is physio-
logic or pathologic.
Limitations in the current study include that IL17 IF analysis was not evaluated in peri-
odontitis lesions. Comparisons are therefore limited to the analyses performed.
Conclusions
Three histologic subtypes of CCUS include granulomatous, lichenoid inflammation and
deep stomatitis. Leukocyte numbers and distribution are consistent across the CCUS cases
and differ from normal and periodontitis controls. CCUS is a heterogeneous, pleocelluar
chronic inflammatory mucosal disease, and regulatory FoxP3+ and CD3-/IL17+ cells are
involved in the pathogenesis. IL17 positive cells in CCUS are mononuclear and primarily CD3
negative.
IL17+ cell frequencies were negatively correlated with the clinical scoring system. Direct
immunofluorescence did not support an autoantibody auto-immune disease process.
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